Gene · 53335
Papers3,029
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
981 to 1,000 of 3,029
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Genetic and Epigenetic Therapies for β-Thalassaemia by Altering the Expression of α-Globin Gene. | Front Genome Ed | 2021 | 34713267 | PubTator, text mining | PubMed |
| Base and Prime Editing Technologies for Blood Disorders. | Front Genome Ed | 2021 | 34713251 | PubTator, text mining | PubMed |
| Gene Editing of Hematopoietic Stem Cells: Hopes and Hurdles Toward Clinical Translation. | Front Genome Ed | 2021 | 34713250 | PubTator, text mining | PubMed |
| The Promise and the Hope of Gene Therapy. | Front Genome Ed | 2021 | 34713249 | PubTator, text mining | PubMed |
| Recent Approaches for Manipulating Globin Gene Expression in Treating Hemoglobinopathies. | Front Genome Ed | 2021 | 34713248 | PubTator, text mining | PubMed |
| Baboon Envelope Pseudotyped "Nanoblades" Carrying Cas9/gRNA Complexes Allow Efficient Genome Editing in Human T, B, and CD34+ Cells and Knock-in of AAV6-Encoded Donor DNA in CD34+ Cells. | Front Genome Ed | 2021 | 34713246 | PubTator, text mining | PubMed |
| Diabetes: Concepts of β-Cell Organ Dysfunction and Failure Would Lead to Earlier Diagnoses and Prevention. | Diabetes | 2021 | 34711669 | PubTator, text mining | PubMed |
| A Review on the Carcinogenic Roles of DSCAM-AS1. | Front Cell Dev Biol | 2021 | 34708048 | PubTator, text mining | PubMed |
| Evaluation of two in vitro assays for tumorigenicity assessment of CRISPR-Cas9 genome-edited cells. | Mol Ther Methods Clin Dev | 2021 | 34703845 | PubTator, text mining | PubMed |
| Mesenchymal stem cell treatment improves outcome of COVID-19 patients via multiple immunomodulatory mechanisms. | Cell Res | 2021 | 34702946 | PubTator, text mining | PubMed |
| Significance of genetic modifiers of hemoglobinopathies leading towards precision medicine. | Sci Rep | 2021 | 34686692 | PubTator, text mining | PubMed |
| The Role of miRNAs as Therapeutic Tools in Sickle Cell Disease. | Medicina (Kaunas) | 2021 | 34684143 | PubTator, text mining | PubMed |
| CRISPR/Cas9 Delivery System Engineering for Genome Editing in Therapeutic Applications. | Pharmaceutics | 2021 | 34683943 | PubTator, text mining | PubMed |
| Hodgkin Lymphoma: A Special Microenvironment. | J Clin Med | 2021 | 34682791 | PubTator, text mining | PubMed |
| A longitudinal study of gene expression in first-episode schizophrenia; exploring relapse mechanisms by co-expression analysis in peripheral blood. | Transl Psychiatry | 2021 | 34667144 | PubTator, text mining | PubMed |
| Advanced Nanotheranostics of CRISPR/Cas for Viral Hepatitis and Hepatocellular Carcinoma. | Adv Sci (Weinh) | 2021 | 34665528 | PubTator, text mining | PubMed |
| Enhanced prime editing systems by manipulating cellular determinants of editing outcomes. | Cell | 2021 | 34653350 | PubTator, text mining | PubMed |
| Comparison of the Feasibility, Efficiency, and Safety of Genome Editing Technologies. | Int J Mol Sci | 2021 | 34638696 | PubTator, text mining | PubMed |
| Pathogenic BCL11A variants provide insights into the mechanisms of human fetal hemoglobin silencing. | PLoS Genet | 2021 | 34634037 | PubTator, text mining | PubMed |
| Genomics in medicine: A new era in medicine. | World J Methodol | 2021 | 34631481 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/53335/papers?page=50